(UroToday.com) In this abstract, Ms. Spieler looks at the timing of adjuvant vs. progression-triggered treatment with gemcitabine in platinum-ineligible patients with pT3-4 or N+M0 urothelial carcinoma following radical cystectomy.
(UroToday.com) In this abstract, Ms. Spieler looks at the timing of adjuvant vs. progression-triggered treatment with gemcitabine in platinum-ineligible patients with pT3-4 or N+M0 urothelial carcinoma following radical cystectomy.